Non-Institutional Investors (NIIs) for 7,64,400 shares, while individual investors (IND category bidding for 2 lots) placed bids for 15,45,600 shares.

The issue opened for bidding on Thursday (18 December 2025) and it closed on Monday (22 December 2025). The price band of the IPO was at Rs 98 per share. The minimum order quantity is 1,200 equity shares. The equity shares will list on BSE’s SME platform.

The IPO comprised fresh issue of 39,00,000 equity shares. The promoter and promoter shareholding diluted to 66.68% from 100% Pre-IPO.

The company intends to utilize the net proceeds for funding capital expenditure requirements for the purchase of equipment/machineries, funding capital expenditure requirements towards civil construction, repayment/pre-payment, in full or in part, of certain borrowings availed by company and for general corporate purpose.

Phytochem Remedies (India) is engaged in the manufacturing of corrugated boxes and corrugated board solutions. The company primarily caters to customers across industries such as food and beverages, fast-moving consumer goods (FMCG), pesticides, pharmaceuticals, and automotive.

The company operates two manufacturing units located at Bari Brahmana, Jammu. Unit 1 has a total allocated area of 43,360 square feet, of which approximately 12,000 square feet is currently utilised.

Unit 2 has an allocated area of 1,73,440 square feet, with around 55,000 square feet presently under utilisation. Phytochem Remedies offers a wide range of packaging products, including 3-ply, 5-ply and 7-ply corrugated boxes, printed corrugated boxes, corrugated rolls, as well as corrugated pads and sheets. As of 30 September 2025, the company had 51 employees.

The company recorded revenue from operations of Rs 24.82 crore and net profit of Rs 3.75 crore for the period ended 30 September 2025.